{"id":36183,"date":"2025-04-03T14:44:51","date_gmt":"2025-04-03T13:44:51","guid":{"rendered":"https:\/\/www.alantra.com\/?post_type=ib-transaction&#038;p=36183"},"modified":"2025-04-03T14:45:28","modified_gmt":"2025-04-03T13:45:28","slug":"clinica-baviera-accelerated-bookbuilding","status":"publish","type":"ib-transaction","link":"https:\/\/www.alantra.com\/es\/ib-transaction\/clinica-baviera-accelerated-bookbuilding\/","title":{"rendered":"Alantra Acts as Global Coordinator in the c.\u20ac42.4mn Placement of Clinica Baviera\u2019s Shares"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Madrid &#8211; <\/strong>Alantra is pleased to announce the successful completion of the Accelerated Bookbuilding (ABB) of Cl\u00ednica Baviera\u2019s shares. Alantra acted as the sole Global Coordinator in the placement of 1,304,606 shares, representing 8% of the company\u2019s share capital, at a price of \u20ac32.50 per share, raising a total of approximately \u20ac42.4mn. The shares were sold by Aier Eye, Cl\u00ednica Baviera\u2019s majority shareholder and a leading Chinese ophthalmology group, and Vito Gesti\u00f3n, the investment vehicle of the Baviera family.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The transaction attracted strong demand from Tier 1 institutional investors across multiple geographies, with 55% of the allocation going to the UK, followed by France (13%), Spain (13%), Italy (10%), and Germany (9%). The placement significantly increases Cl\u00ednica Baviera\u2019s free float to 20%, enhancing the stock\u2019s liquidity and setting the stage for the company\u2019s next phase as a listed entity.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.alantra.com\/team-member\/andre-pereira-ambrosio\/\" target=\"_blank\" rel=\"noreferrer noopener\">Andr\u00e9 Pereira<\/a>, Partner and Head of ECM at Alantra Equities, said: \u201cWe are pleased to have supported Cl\u00ednica Baviera and its shareholders in this successful placement, which opens a new phase for Clinica Baviera as a listed entity on the back of the free float increase and the diversification of Baviera\u2019s investor base. This transaction reflects the strong investor appetite for quality capital markets opportunities in the small and mid-cap space. With proper investor education and extensive marketing, high quality issuers like Clinica Baviera are capable of attracting capital at competitive prices. This was a joint effort with our Milan team, and a landmark transaction for Alantra, which actively engaged with over 50 investors to build a well-balanced book.\u201d&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This transaction underscores Alantra\u2019s momentum in advising on high-profile Equity Capital Markets transactions in Iberia. Recently, the firm acted as Co-Lead Manager for HBX Group\u2019s IPO and Joint Bookrunner for Cox\u2019s IPO on the Madrid Stock Exchange.<\/p>\n\n\n    <div class=\"button--block \">\n        <div class=\"button--block_box\">\n                                                                <a href=\"https:\/\/www.alantra.com\/es\/spain-equity-capital-markets\/spain-equity-capital-markets\/\" class=\"btn\" target=\"_blank\">View Spain <span class=\"btn__arrow\"><\/span><\/a>\n                                                                                <a href=\"https:\/\/www.alantra.com\/what-we-do\/investment-banking\/transactions\/?sector=healthcare\" class=\"btn\" target=\"_blank\">View Healthcare <span class=\"btn__arrow\"><\/span><\/a>\n                                    <\/div>\n    <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Madrid &#8211; Alantra is pleased to announce the successful completion of the Accelerated Bookbuilding (ABB) of Cl\u00ednica Baviera\u2019s shares. Alantra acted as the sole Global Coordinator in the placement of 1,304,606 shares, representing 8% of the company\u2019s share capital, at a price of \u20ac32.50 per share, raising a total of approximately \u20ac42.4mn. The shares were [&hellip;]<\/p>\n","protected":false},"featured_media":34681,"parent":0,"template":"","meta":{"_acf_changed":false},"country":[22,8],"ib-service":[96],"sector":[52],"class_list":["post-36183","ib-transaction","type-ib-transaction","status-publish","has-post-thumbnail","hentry","country-italy","country-spain","ib-service-equity-capital-markets","sector-healthcare"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/ib-transaction\/36183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/ib-transaction"}],"about":[{"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/types\/ib-transaction"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/media\/34681"}],"wp:attachment":[{"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/media?parent=36183"}],"wp:term":[{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/country?post=36183"},{"taxonomy":"ib-service","embeddable":true,"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/ib-service?post=36183"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.alantra.com\/es\/wp-json\/wp\/v2\/sector?post=36183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}